The Lancet Oncology in conversation with

Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma

January 02, 2024 The Lancet Group
The Lancet Oncology in conversation with
Shankar Siva on stereotactic body radiotherapy for primary renal cell carcinoma
Show Notes

Senior Editor Owen Stretton talks to Professor Shankar Siva from the Peter MacCallum Cancer Centre in Melbourne about the International Society of Stereotactic Radiosurgery’s new systematic review and practice guidelines for stereotactic body radiotherapy in primary renal cell carcinoma.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv